Therefore, it may be possible that TDF downregulates adenosine and A2AR levels, which results in the inhibition of PI3K/Akt/mTOR phosphorylation and ultimately leads to HSC apoptosis and the amelioration of liver fibrosis. This evidence concerns the gene ADORA2A and Hepatic fibrosis.